Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spatiotemporal spread of Plasmodium falciparum mutations for resistance to sulfadoxine-pyrimethamine across Africa, 1990–2020
Jennifer A. Flegg, Georgina Humphreys, Brenda Montanez, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 8, pp. e1010317-e1010317
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin–piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial
Hellen C. Barsosio, Mwayiwawo Madanitsa, Everlyne D. Ondieki, et al.
The Lancet (2024) Vol. 403, Iss. 10424, pp. 365-378
Open Access | Times Cited: 10
Prevalence of and risk factors for microscopic and submicroscopic malaria infections in pregnancy: a systematic review and meta-analysis
Anna Maria van Eijk, Kasia Stepniewska, Achille Massougbodji, et al.
The Lancet Global Health (2023) Vol. 11, Iss. 7, pp. e1061-e1074
Open Access | Times Cited: 18
Spatio-temporal spread of artemisinin resistance in Southeast Asia
Jennifer A. Flegg, Sevvandi Kandanaarachchi, Philippe J. Guérin, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 4, pp. e1012017-e1012017
Open Access | Times Cited: 3
Impact of dhps mutations on sulfadoxine-pyrimethamine protective efficacy and implications for malaria chemoprevention
Andria Mousa, Gina Cuomo-Dannenburg, Hayley A Thompson, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Perennial malaria chemoprevention with and without malaria vaccination to reduce malaria burden in young children: a modelling analysis
Manuela Runge, Anne Stahlfeld, Monique Ambrose, et al.
Malaria Journal (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Systematic Review and Meta-Analysis of Seasonal Malaria Chemoprevention
Julie Thwing, John Williamson, I Cavros, et al.
American Journal of Tropical Medicine and Hygiene (2023) Vol. 110, Iss. 1, pp. 20-31
Open Access | Times Cited: 8
Weekly dihydroartemisinin–piperaquine versus monthly sulfadoxine–pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trial
Richard Idro, Thandile Nkosi-Gondwe, Robert O. Opoka, et al.
The Lancet Infectious Diseases (2024)
Open Access | Times Cited: 3
Polymorphism analysis of drug resistance markers in Plasmodium falciparum isolates from Benin
Mariangela L’Episcopia, Cécile Doderer-Lang, Edvige Perrotti, et al.
Acta Tropica (2023) Vol. 245, pp. 106975-106975
Open Access | Times Cited: 8
A spatio-temporal model of multi-marker antimalarial resistance
Yong See Foo, Jennifer A. Flegg
Journal of The Royal Society Interface (2024) Vol. 21, Iss. 210
Open Access | Times Cited: 2
Measuring protective efficacy and quantifying the impact of drug resistance: A novel malaria chemoprevention trial design and methodology
Andria Mousa, Gina Cuomo-Dannenburg, Hayley A Thompson, et al.
PLoS Medicine (2024) Vol. 21, Iss. 5, pp. e1004376-e1004376
Open Access | Times Cited: 2
Seasonal malaria chemoprevention and the spread of Plasmodium falciparum quintuple-mutant parasites resistant to sulfadoxine–pyrimethamine: a modelling study
Thiery Masserey, Tamsin E. Lee, Sherrie L. Kelly, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 9, pp. 100892-100892
Open Access | Times Cited: 2
Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile
Myriam El Gaaloul, André-Marie Tchouatieu, Kassoum Kayentao, et al.
Malaria Journal (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial
Moussa Lingani, Serge Henri Zango, Innocent Valéa, et al.
Malaria Journal (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Systematic Review and Geospatial Modeling of Molecular Markers of Resistance to Artemisinins and Sulfadoxine–Pyrimethamine in Plasmodium falciparum in India
Minu Nain, Mehul Dhorda, Jennifer A. Flegg, et al.
American Journal of Tropical Medicine and Hygiene (2024) Vol. 110, Iss. 5, pp. 910-920
Open Access | Times Cited: 1
Dihydroartemisinin–piperaquine for prevention of malaria in pregnant women living with HIV
Moses R. Kamya, Abel Kakuru, Grant Dorsey
The Lancet (2024) Vol. 403, Iss. 10424, pp. 327-330
Closed Access | Times Cited: 1
Sex-Linked Differences in Malaria Risk Across the Lifespan
Jessica Briggs, Margaret Murray, Jason Nideffer, et al.
Current topics in microbiology and immunology (2023), pp. 185-208
Closed Access | Times Cited: 3
Seasonal malaria chemoprevention in Africa and China’s upgraded role as a contributor: a scoping review
Ming Xu, Yun-Xuan Hu, Shenning Lu, et al.
Infectious Diseases of Poverty (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Comparison of new computational methods for spatial modelling of malaria
Spencer Wong, Jennifer A. Flegg, Nick Golding, et al.
Malaria Journal (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a two-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus artesunate monotherapy among asymptomatic children 3-5 years of age in Zambia
Rosario Martinez-Vega, Mike Chaponda, Andria Mousa, et al.
Research Square (Research Square) (2024)
Open Access
Seasonal malaria chemoprevention and the spread ofPlasmodium falciparumquintuple mutant parasites resistant to sulfadoxine-pyrimethamine: a modelling study
Thiery Masserey, Tamsin E. Lee, Sherrie L. Kelly, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Peripheral and Placental Prevalence of Sulfadoxine–Pyrimethamine Resistance Markers in Plasmodium falciparum among Pregnant Women in Southern Province, Rwanda
Muharib Alruwaili, Aline Uwimana, Reena Sethi, et al.
American Journal of Tropical Medicine and Hygiene (2023) Vol. 109, Iss. 5, pp. 1057-1062
Open Access | Times Cited: 1
A spatiotemporal model of multi-marker antimalarial resistance
Yong See Foo, Jennifer A. Flegg
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Rapid assessments for the deployment of seasonal malaria chemoprevention in new geographies of east and southern Africa: protocol for a hybrid type II implementation study. (Preprint)
Maria Suau Sans, Chukwudi A Nnaji, Sam Gudoi, et al.
JMIR Research Protocols (2023)
Open Access | Times Cited: 1
Genome-wide association study of global Plasmodium vivax populations provides insights into the evolution of drug resistance
Gabrielle C. Ngwana-Joseph, Jody Phelan, Emilia Mańko, et al.
Research Square (Research Square) (2024)
Open Access
Prévention du paludisme en Afrique subsaharienne : états des lieux, enjeux et perspectives
Paul Sondo, Innocent Valéa, Armel Poda, et al.
Médecine et Maladies Infectieuses Formation (2024) Vol. 3, Iss. 2, pp. 73-78
Closed Access
Page 1 - Next Page

Scroll to top